Search

Thomas M. Cunningham

Examiner (ID: 5862)

Most Active Art Unit
1813
Art Unit(s)
1806, 1644, 1813, 2899, 1816, 2900
Total Applications
454
Issued Applications
198
Pending Applications
72
Abandoned Applications
184

Applications

Application numberTitle of the applicationFiling DateStatus
08/007406 METHODS AND COMPOSITIONS FOR EARLY DETECTION AND TREATMENT OF INSULIN DEPENDENT DIABETES MELLITUS Jan 21, 1993 Abandoned
Array ( [id] => 3682466 [patent_doc_number] => 05633234 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Lysosomal targeting of immunogens' [patent_app_type] => 1 [patent_app_number] => 8/006845 [patent_app_country] => US [patent_app_date] => 1993-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 19 [patent_no_of_words] => 15661 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633234.pdf [firstpage_image] =>[orig_patent_app_number] => 006845 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/006845
Lysosomal targeting of immunogens Jan 21, 1993 Issued
08/007049 HUMAN RHINOVIRUS RECEPTOR PROTEIN THAT INHIBITS VIRUS INFECTIVITY Jan 20, 1993 Abandoned
Array ( [id] => 3051962 [patent_doc_number] => 05324822 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-28 [patent_title] => 'Method of isolating a CA 195-like immunoreactive antigen from human amniotic fluid' [patent_app_type] => 1 [patent_app_number] => 7/993588 [patent_app_country] => US [patent_app_date] => 1992-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2412 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/324/05324822.pdf [firstpage_image] =>[orig_patent_app_number] => 993588 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/993588
Method of isolating a CA 195-like immunoreactive antigen from human amniotic fluid Dec 20, 1992 Issued
Array ( [id] => 3009960 [patent_doc_number] => 05308614 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-03 [patent_title] => 'Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones' [patent_app_type] => 1 [patent_app_number] => 7/996509 [patent_app_country] => US [patent_app_date] => 1992-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 7666 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/308/05308614.pdf [firstpage_image] =>[orig_patent_app_number] => 996509 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/996509
Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones Dec 20, 1992 Issued
07/992942 VACCINATION WITH PEPTIDE OF MHC CLASS II MOLECULES FOR TREATMENT OF AUTOIMMUNE DISEASE Dec 16, 1992 Abandoned
07/989641 MALARIA-SPECIFIC DNA SEQUENCES, EXPRESSION PRODUCTS THEREOF, AND THE USE THEREOF Dec 10, 1992 Abandoned
07/987571 VACCINATION AGAINST DISEASES RESULTING FROM PATHOGENIC RESPONSES BY SPECIFIC T CELL POPULATIONS Dec 7, 1992 Abandoned
07/985750 HETEROFUNCTIONAL CELLULAR IMMUNOLOGICAL REAGENTS, VACCINES CONTAINING SAME AND METHODS FOR THE USE OF SAME Dec 3, 1992 Abandoned
07/978946 MHC SUBUNIT CONJUGATES USEFUL IN AMELIORATING DELETERIOUS IMMUNE RESPONSES Nov 17, 1992 Abandoned
07/977589 MULTIMERIC FORM OF HUMAN RHINOVIRUS RECEPTOR PROTEIN Nov 16, 1992 Abandoned
07/977590 MULTIMERIC FORMS OF HUMAN RHINOVIRUS RECEPTOR PROTEIN Nov 16, 1992 Abandoned
07/977057 COMPOSITIONS AND METHOD USING MICROENCAPSULATED MONOCLONAL ANTIBODIES Nov 15, 1992 Abandoned
Array ( [id] => 3407683 [patent_doc_number] => 05437864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-01 [patent_title] => 'Method of inhibiting blood coagulation in extracorporeal circulation by inhibiting human tissue factor' [patent_app_type] => 1 [patent_app_number] => 7/977281 [patent_app_country] => US [patent_app_date] => 1992-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 31 [patent_no_of_words] => 32239 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/437/05437864.pdf [firstpage_image] =>[orig_patent_app_number] => 977281 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/977281
Method of inhibiting blood coagulation in extracorporeal circulation by inhibiting human tissue factor Nov 15, 1992 Issued
Array ( [id] => 3091810 [patent_doc_number] => 05312810 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-17 [patent_title] => 'Method and compositions for making ACSF and ACSF antagonists' [patent_app_type] => 1 [patent_app_number] => 7/975960 [patent_app_country] => US [patent_app_date] => 1992-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9515 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/312/05312810.pdf [firstpage_image] =>[orig_patent_app_number] => 975960 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/975960
Method and compositions for making ACSF and ACSF antagonists Nov 12, 1992 Issued
07/974334 VACCINATION AGAINST DISEASE RESULTING FROM PATHOGENIC RESPONSES BY SPECIFIC T CELL POPULATIONS Nov 9, 1992 Abandoned
Array ( [id] => 2989681 [patent_doc_number] => 05366728 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-22 [patent_title] => 'Stable forms of antigenic Taenia ovis polypeptides' [patent_app_type] => 1 [patent_app_number] => 7/969450 [patent_app_country] => US [patent_app_date] => 1992-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5603 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/366/05366728.pdf [firstpage_image] =>[orig_patent_app_number] => 969450 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/969450
Stable forms of antigenic Taenia ovis polypeptides Oct 29, 1992 Issued
07/940640 METHOD FOR INDUCTION OF ANTIGEN-SPECIFIC IMMUNE TOLERANCE Sep 3, 1992 Abandoned
Array ( [id] => 3648197 [patent_doc_number] => 05637677 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Biologically active compounds and methods of constructing and using the same' [patent_app_type] => 1 [patent_app_number] => 7/940654 [patent_app_country] => US [patent_app_date] => 1992-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 48 [patent_no_of_words] => 23664 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637677.pdf [firstpage_image] =>[orig_patent_app_number] => 940654 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/940654
Biologically active compounds and methods of constructing and using the same Sep 2, 1992 Issued
07/937449 DIAGNOSIS AND TREATMENT OF INSULIN DEPENDENT DIABETES MELLUTUS Aug 30, 1992 Abandoned
Menu